{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:23:33Z","timestamp":1761708213458,"version":"3.35.0"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2618,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1111\/j.1540-8191.2008.00600.x","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T07:04:49Z","timestamp":1213686289000},"page":"312-320","source":"Crossref","is-referenced-by-count":24,"title":["Atorvastatin Increases Myocardial Indices of Oxidative Stress in a Porcine Model of Hypercholesterolemia and Chronic Ischemia"],"prefix":"10.1155","volume":"23","author":[{"given":"Neel R.","family":"Sodha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Boodhwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Ramlawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetoshi","family":"Mieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesario","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank W.","family":"Sellke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0735-1097(00)01144-X","article-title":"Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia","volume":"37","author":"Sato","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1111\/j.1540-8191.2008.00600.x-BIB2","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0003-4975(00)02018-X","article-title":"Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia","volume":"70","author":"Sato","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)35353-4","article-title":"Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia","volume":"292","author":"Laham","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0008-6363(98)00136-9","article-title":"VEGF administration in chronic myocardial ischemia in pigs","volume":"40","author":"Lopez","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1111\/j.1540-8191.2008.00600.x-BIB5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1111\/j.1540-8191.2008.00600.x-BIB6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1111\/j.1540-8191.2008.00600.x-BIB7","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","article-title":"Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT)","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mtc.2002.121974","article-title":"Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein","volume":"124","author":"Ruel","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1111\/j.1540-8191.2008.00600.x-BIB9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: The Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1111\/j.1540-8191.2008.00600.x-BIB10","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1161\/01.CIR.102.11.e73","article-title":"Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary","volume":"102","author":"Simons","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1111\/j.1540-8191.2008.00600.x-BIB11","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB12","first-page":"81","article-title":"Molecular and cellular basis of myocardial angiogenesis","volume":"40","author":"Granger","year":"1994","journal-title":"Cell Mol Biol Res"},{"issue":"19 Suppl 3","key":"10.1111\/j.1540-8191.2008.00600.x-BIB13","first-page":"III370","article-title":"Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: Nitric oxide-dependent mechanism","volume":"102","author":"Duan","year":"2000","journal-title":"Circulation"},{"issue":"18","key":"10.1111\/j.1540-8191.2008.00600.x-BIB14","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.0000015856.84385.E9","article-title":"Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide","volume":"105","author":"Matsunaga","year":"2002","journal-title":"Circulation"},{"issue":"1 Suppl","key":"10.1111\/j.1540-8191.2008.00600.x-BIB15","first-page":"I402","article-title":"High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response","volume":"114","author":"Boodhwani","year":"2006","journal-title":"Circulation"},{"issue":"19 Suppl","key":"10.1111\/j.1540-8191.2008.00600.x-BIB16","first-page":"II242","article-title":"Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia","volume":"98","author":"Tofukuji","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/000331970605700212","article-title":"Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects","volume":"57","author":"Marketou","year":"2006","journal-title":"Angiology"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1507\/endocrj.52.259","article-title":"Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients","volume":"52","author":"Miwa","year":"2005","journal-title":"Endocr J"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2004.03.060","article-title":"Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina","volume":"101","author":"Karatzis","year":"2005","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10557-006-6752-x","article-title":"Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients \u2018on\u2019 and \u2018off\u2019 atorvastatin for short time intervals","volume":"20","author":"Thomas","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"10.1111\/j.1540-8191.2008.00600.x-BIB21","first-page":"914","article-title":"Fluvastatin reduces oxidative stress, decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia","volume":"103","author":"Leu","year":"2004","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2003.09.018","article-title":"Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg\/dl","volume":"93","author":"Wassmann","year":"2004","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5551\/jat.13.68","article-title":"Probucol and atorvastatin decrease urinary 8-hydroxy-2\u2032-deoxyguanosine in patients with diabetes and hypercholesterolemia","volume":"13","author":"Endo","year":"2006","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"10.1111\/j.1540-8191.2008.00600.x-BIB24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00380-005-0833-9","article-title":"Effects of atorvastatin on inflammation and oxidative stress","volume":"20","author":"Sugiyama","year":"2005","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1111\/j.1540-8191.2008.00600.x-BIB25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbagen.2004.06.023","article-title":"Do the serum oxidative stress biomarkers provide a reasonable index of the general oxidative stress status?","volume":"1674","author":"Arguelles","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1111\/j.1540-8191.2008.00600.x-BIB26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/00002018-200528080-00002","article-title":"The effect of HMG-CoA reductase inhibitors on coenzyme Q10: Possible biochemical\/clinical implications","volume":"28","author":"Hargreaves","year":"2005","journal-title":"Drug Saf"},{"issue":"12","key":"10.1111\/j.1540-8191.2008.00600.x-BIB27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1253\/circj.69.1547","article-title":"Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis","volume":"69","author":"Katsumoto","year":"2005","journal-title":"Circ J"},{"issue":"2","key":"10.1111\/j.1540-8191.2008.00600.x-BIB28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.RES.0000028149.15986.4C","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA","volume":"91","author":"Park","year":"2002","journal-title":"Circ Res"},{"issue":"6","key":"10.1111\/j.1540-8191.2008.00600.x-BIB29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00041433-200312000-00008","article-title":"Statin therapy and angiogenesis","volume":"14","author":"Skaletz-Rorowski","year":"2003","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1111\/j.1540-8191.2008.00600.x-BIB30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-2004-869596","article-title":"The pro- and antiangiogenic effects of statins","volume":"4","author":"Skaletz-Rorowski","year":"2004","journal-title":"Semin Vasc Med"},{"issue":"3","key":"10.1111\/j.1540-8191.2008.00600.x-BIB31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0008-6363(00)00285-6","article-title":"Experimental evaluation of coronary collateral development","volume":"49","author":"Unger","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1111\/j.1540-8191.2008.00600.x-BIB32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1152\/japplphysiol.00465.2002","article-title":"Translational physiology: Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis","volume":"94","author":"Hughes","year":"2003","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0033-0620(77)80005-4","article-title":"Blood flow measurements with radionuclide-labeled particles","volume":"20","author":"Heymann","year":"1977","journal-title":"Prog Cardiovasc Dis."},{"issue":"15 Pt 1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB34","first-page":"20","article-title":"Uses and abuses of the radioactive microsphere method of measuring regional blood flow","author":"Hoffman","year":"1977","journal-title":"Bibl Anat"},{"issue":"1","key":"10.1111\/j.1540-8191.2008.00600.x-BIB35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2007.01.040","article-title":"Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function","volume":"125","author":"Sakabe","year":"2008","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1111\/j.1540-8191.2008.00600.x-BIB36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.numecd.2006.10.008","article-title":"Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function","volume":"18","author":"Sakabe","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3-4","key":"10.1111\/j.1540-8191.2008.00600.x-BIB37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10354-007-0377-y","article-title":"Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease","volume":"157","author":"Alber","year":"2007","journal-title":"Wien Med Wochenschr"},{"issue":"8","key":"10.1111\/j.1540-8191.2008.00600.x-BIB38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/clc.4960290808","article-title":"The effects of atorvastatin on coronary endothelial function in patients with recent myocardial infarction","volume":"29","author":"Hosokawa","year":"2006","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1111\/j.1540-8191.2008.00600.x-BIB39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ahj.2004.06.027","article-title":"Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients","volume":"149","author":"John","year":"2005","journal-title":"Am Heart J"},{"issue":"9","key":"10.1111\/j.1540-8191.2008.00600.x-BIB40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ehj.2004.03.013","article-title":"Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: Results from the LIPID study","volume":"25","author":"Colquhoun","year":"2004","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiac Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8191.2008.00600.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1540-8191.2008.00600.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:32:41Z","timestamp":1738261961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8191.2008.00600.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1540-8191.2008.00600.x","relation":{},"ISSN":["0886-0440","1540-8191"],"issn-type":[{"type":"print","value":"0886-0440"},{"type":"electronic","value":"1540-8191"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}